Pentamidine prevented pneumocystosis among pediatric HSCT patients

May 2013
Hem/Onc Today;5/25/2013, Vol. 14 Issue 10, p8
The article discusses the findings of a retrospective study which revealed the safety and efficacy of using intravenous pentamidine for the prevention of Pneumocystis carinii pneumonia in pediatric patients who underwent hematopoietic stem cell transplantation.


Related Articles

  • Pneumocystis carinii Pneumonia Preceding Childhood Lvmphoma. Jong-Jin Seo; Ghim, Thad T. // Clinical Pediatrics;Feb1993, Vol. 32 Issue 2, p126 

    Presents a letter to the editor of the periodical "Clinical Pediatrics" about an article on pneumocystis carinii pneumonia preceding childhood lymphoma.

  • Variable use of therapeutic interventions for children with human immunodeficiency virus type 1 infection in Europe. Bernardi, S.; Thorne, C.; Newell, M. -L.; Giaquinto, C.; Tovo, P. -A.; Rossi, P. // European Journal of Pediatrics;2000, Vol. 159 Issue 3, p170 

    Unlabelled: Although a range of antiretroviral drugs are available for use in children, the appropriate paediatric regimen remains unclear. In a survey to investigate policies and practices relating to the therapeutic management of children infected by the human immunodeficiency...

  • Interstitial Pneumonia Caused by Protozoan Pneumocystis Ca- ninii. Cooper, M.; Kaftori, J.; Winter, S. T. // Clinical Pediatrics;Nov1962, Vol. 1 Issue 2, p130 

    Focuses in interstitial pneumonia caused by protozoan Pneumocystis caninii in chilren in Israel.

  • Pneumocystis jirovecii pneumonia in a baby with hyper-IgE syndrome. Garty, Ben Zion; Ben-Baruch, Adit; Rolinsky, Asaf; Woellner, Cristina; Grimbacher, Bodo; Marcus, Nufar // European Journal of Pediatrics. Supplement;2010, Vol. 169, p35 

    A 4-month-old baby with a family history of hyper-IgE syndrome acquired Pneumocystis jirovecii pneumonia. The patient's hyper-IgE syndrome score was low, but a genetic study yielded a STAT3 mutation. P. jirovecii pneumonia can be added to the infections associated with hyper-IgE syndrome. In...

  • Management of Pneumocystis jiroveci Pneumonia in Children Receiving Chemotherapy. Shankar, Sadhna M.; Nania, Joseph J. // Pediatric Drugs;2007, Vol. 9 Issue 5, p301 

    Pneumocystis jiroveci (formerly carinii) pneumonia (PCP) is a serious opportunistic infection in children and adolescents with cancer. It was the most common cause of death among children receiving chemotherapy prior to the inclusion of PCP prophylaxis as part of standard care for children with...

  • Necrotizing Enterocolitis With Hepatic Portal Venous Gas And Pneumatosis Intestinalis In A Patient With AIDS. Baig, Muhammad Ahsan; Rasheed, Javeria; Lin, Yu-Shia; Smith, Peter R. // Internet Journal of Infectious Diseases;2006, Vol. 5 Issue 1, p5 

    A 43-year-old man was admitted in our hospital because of severe Pneumocystis jerovecii pneumonia [formerly called Pneumocystis Carinii Pneumonia (PCP)]. During his stay in Intensive care unit, he developed vomiting, abdominal distension and absent bowel sounds. On abdominal radiograph, hepatic...

  • Therapy of Pneumocystis Pneumonia.  // Clinical Pediatrics;Nov1977, Vol. 16 Issue 11, p1068 

    Reports on findings of a study on the use of pentamidine isethionate for the treatment of Pneumocystis pneumonia and the early stages of Gambian sleeping sickness on children in the United States. Data gathered on patients with suspected or confirmed Pneumocystis pneumonia during the first three...

  • The Parasitic Diseases of Childhood. KAGAN, IRVING G.; FOX, HOWARD A.; WALLS, KENNETH W.; HEALY, GEORGE R. // Clinical Pediatrics;Nov1967, Vol. 6 Issue 11, p641 

    The ubiquitousness of certain protozoan and helminth parasites and the increasing geographic mobility of individuals point up the need for an awareness of the role of parasitic infections in pediatric practice, This paper (a) surveys the advances in diagnosis and clinical understanding of those...

  • Pneumocystis carinii pneumonia.  // Modern Medicine;Aug95, Vol. 63 Issue 8, p26 

    Reports on the US Food and Drug Administration's approval on the marketing of a suspension form of atovaquone in the treatment of pneumocystis carinii pneumonia. Advantages and convenience; Dosage.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics